Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 2.870
-0.040 (-1.37%)
Aug 15, 2025, 5:30 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 95.79 million as of August 15, 2025. Its market cap has decreased by -50.40% in one year.
Market Cap
95.79M
Enterprise Value
-32.98M
Revenue
2.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.87
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 95.79M, a decrease of -77.52%. That is a compound annual growth rate of -12.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 95.79M | -36.00% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | 604.78M | 60.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 214.27B |
| Novartis AG | 188.78B |
| Lonza Group AG | 38.89B |
| Alcon | 34.73B |
| Galderma Group AG | 31.01B |
| Sandoz Group AG | 20.60B |
| Straumann Holding AG | 15.19B |
| Sonova Holding AG | 13.47B |